The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps you find those companies with a strong foundation that are best positioned to capitalize on future success.
Here are today's top-performing health care Small-Cap Stars as of noon on the east coast:
Accelerate Diagnostics Inc (AXDX)
Accelerate Diagnostics Inc gained 7.34% to $17.11 in morning trading today. Volume reached 102,277 by noon. The stock's average daily volume is 346,286 shares. Accelerate Diagnostics Inc has a 52-week high of $31.86 and a 52-week low of $6.86, and its 50-day SMA and 200-day SMA are $23.79 and $17.47 respectively.
Accelerate Diagnostics Inc develops BACcel system, planned for rapid diagnosis in life-threatening infectious pathogens. It has also developed and licensed OptiChem surface coatings for use in microarraying components.
Zogenix Inc. (ZGNX)
Zogenix Inc. gained 7.09% to $1.44 in morning trading today. Volume reached 989,758 by noon. The stock's average daily volume is 2,448,734 shares. Zogenix Inc. has a 52-week high of $5.19 and a 52-week low of $1.19, and its 50-day SMA and 200-day SMA are $1.80 and $2.91 respectively.
Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.
Therapeuticsmd (TXMD)
Therapeuticsmd gained 6.44% to $4.79 in morning trading today. Volume reached 521,253 by noon. The stock's average daily volume is 2,640,885 shares. Therapeuticsmd has a 52-week high of $9.01 and a 52-week low of $2.03, and its 50-day SMA and 200-day SMA are $4.57 and $5.07 respectively.
TherapeuticsMD Inc is a specialty pharmaceutical company. It develops and markets branded prescription, generic prescription, and over-the-counter (non-prescription) products exclusively for women.
Navidea Biopharmaceuticals (NAVB)
Navidea Biopharmaceuticals gained 4.92% to $1.28 in morning trading today. Volume reached 178,808 by noon. The stock's average daily volume is 663,353 shares. Navidea Biopharmaceuticals has a 52-week high of $3.15 and a 52-week low of $1.11, and its 50-day SMA and 200-day SMA are $1.49 and $1.73 respectively.
Navidea Biopharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of precision diagnostics and radiopharmaceutical agent.
Cerus Corporation (CERS)
Cerus Corporation gained 4.16% to $3.76 in morning trading today. Volume reached 196,033 by noon. The stock's average daily volume is 627,775 shares. Cerus Corporation has a 52-week high of $8.00 and a 52-week low of $3.48, and its 50-day SMA and 200-day SMA are $4.02 and $5.37 respectively.
Cerus Corp is a biomedical products company, which focuses on commercializing the INTERCEPT Blood System to enhance blood safety.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
There's no crystal ball that will tell you what the outcome of this or that clinical trial is going to be. Even if there were, the one astonishingly wealthy person who owns it probably wouldn't share. But that doesn't mean that investing in the right small-cap health care companies can't pay dividends in the long term. While the future of a company's lead therapy may not be certain, most of its present fundamentals are. And while investing in the small-cap biotech market will always be hit-or-miss, investing in solidly built players should help boost that batting average.
Our Small-Cap Stars system uses a complex statistical regression to isolate those fundamental factors that previous success stories had in common and then identifies those small caps that are the most similar to that profile in the present.
For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most indicative of a small-cap company's potential for success.
All data provided by QuoteMedia and was accurate as of 12:00 pm ET.